Eric Kemp
Psychiatry · Terrell, TXNPI 1174681589
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 146 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations.
Across 146 payments — averaging $16.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$371
- AbbVie$337
- Tris Pharma Inc$305
- Ironshore Pharmaceuticals Inc.$202
- Supernus Pharmaceuticals, Inc.$171
- Alkermes, Inc.$155
- plus $903 from 12 others
What the payments were for
- Food & beverage$2,444100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 30 | $371 |
| AbbVie(2 entities) | 22 | $337 |
| Tris Pharma Inc | 15 | $305 |
| Ironshore Pharmaceuticals Inc. | 12 | $202 |
| Supernus Pharmaceuticals, Inc. | 9 | $171 |
| Alkermes, Inc. | 9 | $155 |
| Otsuka America Pharmaceutical, Inc. | 7 | $125 |
| Corium, LLC | 5 | $122 |
| Teva Pharmaceuticals USA, Inc. | 7 | $116 |
| Johnson & Johnson | 6 | $101 |
| Indivior Inc. | 4 | $94 |
| Collegium Pharmaceutical, Inc. | 4 | $76 |
| Eisai Inc. | 5 | $73 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $56 |
| Neurocrine Biosciences, Inc. | 3 | $52 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| Noven Therapeutics, LLC | 2 | $34 |
| Merck | 1 | $19 |
How this compares
$2,444 in reported general payments places this provider in the 80th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clorazepate Dipotassium | 12 | $6,514 |
| Clozapine | 12 | $876 |
| Clonazepam | 81 | $825 |
| Quetiapine Fumarate | 27 | $618 |
| Divalproex Sodium | 19 | $550 |
| Alprazolam | 42 | $474 |
| Olanzapine | 22 | $423 |
| Gabapentin | 27 | $334 |
| Buspirone Hcl | 30 | $272 |
| Amitriptyline Hcl | 12 | $216 |
| Lorazepam | 44 | $214 |
| Aripiprazole | 14 | $204 |
| Risperidone | 24 | $197 |
| Duloxetine Hcl | 16 | $177 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 14 | $160 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Terrell
- Rakesh JainLake Jackson$7.2M
- Arvinder Pal WaliaAustin$2.5M
- Suresh SureddiPlano$2.2M
- Martin GuerreroEl Paso$2M
- Marty BennettAddison$1.8M
- Matthew BramsHouston$1.5M
- Vikram MehraKaty$1.2M
- Joel HolinerDallas$948K
- Frank ChenHouston$941K
- Alice MaoHouston$850K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.